Cyclooxygenase Inhibition Is Associated with Downregulation of Apolipoprotein AI Promoter Activity in Cultured Hepatoma Cell Line HepG2

Metabolism: Clinical and Experimental

Volumn 53, Issue 2, 2004, Pages 174-181

  Horani, Mohamad H ^b   Gobal, Freij ^b   Haas, Michael J ^b   Wong, Norman C W ^b   Mooradian, Arshag D ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; ACETYLSALICYLIC ACID; APOLIPOPROTEIN A1; ARACHIDONIC ACID; BETA GALACTOSIDASE; CHLORAMPHENICOL ACETYLTRANSFERASE; INDOMETACIN; PROSTACYCLIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTANOID; THROMBOXANE B2;

ACETYLATION; ARTICLE; BETA GALACTOSIDASE GENE; CHLORAMPHENICOL ACETYLTRANSFERASE REPORTER GENE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE CONTROL; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; WESTERN BLOTTING;

EID: 0842306334     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.09.009     Document Type: Article

References (68)

1. Brewer HB Jr, Santamarina-Fojo S, Hoeg JM: The molecular biology of the human plasma apolipoiproteinemia, lipoprotein receptors, and lipoprotein lipase, in Steiner G, Shafrir E (eds): Primary Hyperlipoproteinemia. New York, NY, McGraw-Hill, 1990, pp 43-74
2. Gordon DJ, Probstfield JL, Garrison RJ, et al: High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 79:8-15, 1989
3. Kawahiri M, Maugeais C, Rader D: High-density lipoprotein metabolism: Molecular targets for new therapies for atherosclerosis. Curr Atheroscler Rep 2:363-372, 2000
4. Schultz JR, Verstuyft JG, Gong EL, et al: Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 365:762-764, 1993
5. Murao K, Wada Y, Nakamura T, et al: Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J Biol Chem 273:18959-18965, 1998
6. Haas MJ, Pun K, Reinacher D, et al: Effects of ketoacidosis on rat apolipoprotein AI gene expression: A link with acidosis but not with ketones. J Mol Endocrinol 25:129-139, 2000
7. Haas MJ, Reinacher D, Pun K, et al: Induction of the apolipoprotein AI gene by fasting: A relationship with ketosis but not with ketone bodies. Metabolism 49:1572-1578, 2000
8. Haas MJ, Reinacher D, Li JP, et al: Regulation of ApoAI gene expression with acidosis: Requirement for a transcriptional repressor. J Mol Endocrinol 27:43-57, 2001
9. Haas MJ, Sawaf R, Horani MH, et al: Effect of chromium on apolipoprotein A-I expression in HepG2 cells. Nutrition 19:353-357. 2003
10. 1 mRNA and effects of the hormone on the promoter. Mol Endocrinol 6:943-950, 1992
11. Mooradian AD, Wong NCW, Shah GN: Apolipoprotein AI expression in young and aged rats is modulated by dietary carbohydrates. Metabolism 46:1132-1136, 1997
12. 1 promoter. Biochemistry 35:8281-8288, 1996
13. 1 expression. Biochim Biophys Acta 1259:277-282, 1995
14. Taylor AH, Raymond J, Dionne JM, et al: Glucocorticoid increases rat apolipoprotein A-I promoter activity. J Lipid Res 37:2232-2243, 1996
15. Mooradian AD, Wong NCW, Shah GN: Age-related changes in the responsiveness of apolipoprotein AI to thyroid hormone. Am J Physiol 271:R1602-R1607, 1996
16. Efsen E, Bonacchi A, Pastacaldi S, et al: Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 33:713-721, 2001
17. Mater MK, Pan D, Bergen WG, et al: Arachidonic acid inhibits lipogenic gene expression in 3T3-L1 adipocytes through a prostanoid pathway. J Lipid Res 39:1327-1334, 1998
18. Riquet FB, Lai WF, Birkhead JR, et al: Suppression of type 1 collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol Med 6:705-719, 2000
19. Mater MK, Thelen AP, Jump DB: Arachidonic acid and PGE2 regulation of hepatic lipogenic gene expression. J Lipid Res 40:1045-1052, 1999
20. Dibbs KI, Anteby E, Mallon MA, et al: Transcriptional regulation of human placental corticotropin-releasing factor by prostaglandins and estradiol. Biol Reprod 57:1285-1292, 1997
21. Gardner DG, Schultz HD: Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide. J Clin Invest 86:52-59, 1990
22. Willson TM, Brown PJ, Sternbach DD, et al: The PPARS: From orphan receptors to drug discovery. J Med Chem 43:527-550, 2000
23. Dussault I, Forman BM: Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors. Prostaglandins Other Lipid Mediat 62:1-13, 2000
24. Lefebre AM, Peinado-Onsurke J, Leitersdorf I, et al: Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 17:1756-1764, 1997
25. 1 expression by fibrates. J Biol Chem 273:25713-25720, 1998
26. Wasner HK, Weber S, Partke HJ, et al: INDO treatment causes loss of insulin action in rats: Involvement of prostaglandins in the mechanism of insulin action. Acta Diabetol 31:175-182, 1994
27. Christensen JR, Hammond BJ, Smith GD: Indomethacin inhibits endocytosis and degradation of insulin. Biochem Biophys Res Commun 173:127-133, 1990
28. 1 gene in different cell types. Mol Cell Biol 8:605-614, 1988
29. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051, 1982
30. Herbomel P, Bourachot B, Yaniv M: Two distinct enhancer with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653-662, 1984
31. Goodman HM, McDonald RJ: Cloning of hormone genes from a mixture of cDNA molecules. Methods Enzymol 68:75-90, 1979
32. Clewell DB, Helsinki DR: Supercoil circular DNA-protein complex in Escherichia coli: Purificationand induced conversion to an open circular DNA form. Proc Natl Acad Sci USA 63:1159-1166, 1969
33. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
34. Lehrach H, Diamond D, Wozney JM, et al: RNA molecular weight determinations by gel electrophoresis under denaturing conditions: A critical reexamination. Biochemistry 16:4743-4751, 1977
35. Thomas PS: Hybridization of denatured RNA and small RNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201-5205, 1980
36. Sariban E, Luebbers R, Kufe D: Transcriptional and posttranscriptional control of c-fos gene expression in human monocytes. Mol Cell Biol 8:340-346, 1988
37. Cosgrove DE, Cox GS: Enhancement by theophylline of the butyrate-mediated induction of choriogonadotropin α-subunit in HeLa cells. Arch Biochem Biophys 280:95-102, 1990
38. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
39. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
40. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci USA 76:4350-4354, 1979
41. Kulmacz RJ, Lands WEM: Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins 25:531-540, 1983
42. Phillips HJ: Dye exclusion tests for cell viability, in Kruse PF, Patterson MK (eds): Tissue Culture: Methods and Applications. New York, NY, Academic Press, 1973. pp 406-408
43. Kutchera W, Jones DA, Matsunami N, et al: Protaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci USA 93:4816-4820, 1996
44. Smith WL: Prostanoid biosynthesis and mechanism of action. Am J Physiol 263:F181-191, 1992
45. Knowles BB, Howe CC, Aden DP: Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatic surface antigen. Science 209:497-499, 1980
46. Zannis VI, Breslow JL, SanGiacomo TR, et al: Characterization of the apolipoproteins secreted by human hepatoma cell lines. Biochem 20:7089-7096, 1981
47. Rash JM, Tothblat GH, Sparks CE: Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture. Biochim Biophys Acta 666:294-298, 1981
48. Wang SR, Pessah M, Infante J, et al: Lipid and lipoprotein metabolism in HepG2 cells. Biochim Biophys Acta 961:351-363, 1988
49. Forman BM, Tontonoz P, Chen J, et al: 15-Deoxy-delta 12, 14-prostaglandin J2 is ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812, 1995
50. Mooradian AD, Haas MJ, Wong NCW, et al: Apolipoprotein A-I expression in rats is not altered by troglitazone. Exp Biol Med 227:1001-1005, 2002
51. Trifan OC, Smith RM, Thompson BD, et al: Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem 274:34141-34147, 1999
52. Planaguma A, Titos E, Lopez-Parra M, et al: Aspirin (ASA) regulares 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: Novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J 16:1937-1939, 2002
53. Corssmit EP, Romijin JA, Endert E, et al: Modulation of glucose production by indomethacin and pentoxifylline in healthy humans. Metabolism 45:1458-1465, 1996
54. Moreno-Sanchez R, Bravo C, Vasquez C, et al: Inhibition and uncoupling of oxidative phosphorylation by non-steroidal anti-inflammatory drugs: Study in mitochondria, submitochondrial particles, cells, and whole heart. Biochem Pharmacol 57:743-752, 1999
55. Petrescu I, Tarba C: Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat. Biochim Biophys Acta 1318:385-394, 1997
56. - channels through stimulation of a cyclooxygenase-dependent pathway in a model liver cell line. J Biol Chem 277:11721-11727, 2002
57. Grilli M, Pizzi M, Memo M, et al: Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274:1383-1385, 1996
58. Dong Z, Huang C, Brown RE, et al: Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 272:9962-9970, 1997
59. Huang C, Ma WY, Hanenberger D, et al: Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Biol Chem 272:26325-26331, 1997
60. Widom RL, Ladias JAA, Kouidou S, et al: Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells. Mol Cell Biol 11:677-687, 1991
61. Lam JK, Matsubara S, Mihara K, et al: Insulin induction of apolipoprotein A: Role of SPI. Biochemistry 42:2680-2690, 2003
62. Kagawa A, Azuma H, Akaike M, et al: Aspirin reduces apolipoprotein (a) (apo(a)) production in human hepatocytes by suppression of apo (a) gene transcription. J Biol Chem 274:34111-34115, 1999
63. Diaz A, Munoz E, Johnston R, et al: Regulation of human lung fibroblasts alpha 1 (1) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. J Biol Chem 268:10364-10371, 1993
64. Rapuano BE, Bockman RS: Tumor necrosis factor-alpha stimulates phosphatidyl-inositol breakdown by phospholipase C to coordinately increase the levels of diacylglycerol, free arachidoic acid and prostaglandins in an osteoblast (MC3T3-E1) cell line. Biochem Biophys Acta 1091:374-384, 1991
65. Hardardottir I, Moser AH, Memon R, et al: Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res 13:161-166, 1994
66. Ettinger WH, Varma VK, Sorci-Thomas M, et al: Cytokines decrease apolipoprotein accumulation in medium from HepG2 cells. Arterioscler Thromb 14:8-13, 1994
67. Song H, Saito K, Fugigaki S, et al: IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apoA-I expression in HepG2 cells. Cytokine 10:275-280, 1998
68. Haas MJ, Horani M, Mreyoud A, et al: Suppression of apolipoprotein AI gene expression in HepG2 cells by TNFα and IL-β. Biochim Biophys Acta 1623:120-128, 2003